Frontiers in Neurology · 2018 · 29 citations · 10 references
MedicineNeurologyPharmacotherapyFunctional Movement AssessmentMovement AnalysisNeuropharmacologyGait AssessmentMotor Control AssessmentParkinson DiseaseParkinsonian DisordersClinical Diagnosis Of ParkinsonismClinical Motor ScoringClinical Rating ScalesDisease DurationLevodopa Challenge TestMotor Response TestingParkinson's Disease PharmacotherapyPercent Change Interpretation
BACKGROUND: The levodopa challenge test is routinely used in Parkinson disease (PD) to determine a patient's motor improvement following levodopa administration [levodopa response (LR)]. LR is most commonly reported as a percent OFF to ON change in the Unified Parkinson Disease Rating Scale (UPDRS) part III score, and occasionally as an absolute difference in score. This inconsistency in LR determination alters how clinical factors such as patient age and disease duration are understood in relation to LR in PD. OBJECTIVE: The aim of this study was to compare the calculation of the LR as either a percent change or difference in UPDRS-III motor score between OFF and ON medication. These two scores were then used to correlate to disease duration, patient age, levodopa duration, levodopa equivalent dose (LED), OFF score, cognition, mood, gait, and quality of life (QOL). METHODS: 70 PD patients underwent the levodopa challenge test. The UPDRS-III motor examination was performed in the defined OFF and ON medication states to determine LR. Each patient was assessed after 12-14 h without anti-parkinsonian medication and then given three 100/25 mg levodopa/carbidopa tablets. LR was reported as both a difference in score [OFF - ON; absolute LR (aLR)] and as a percent change in score [(OFF - ON)/OFF*100%; %LR]. Patients completed the following non-motor symptom assessment scales: Montreal Cognitive Assessment, Freezing of Gait Questionnaire, Activities-specific Balance Confidence Scale, Parkinson's Disease Questionnaire, and Geriatric Depression Scale. The effect of the LR calculation method was correlated to the clinical measures. RESULTS: = 0.30). By contrast, the more commonly used %LR demonstrated no significant relationships with any of the variables tested. CONCLUSION: Although the %LR is more commonly employed in clinical protocols and research studies, the aLR is the superior method for reporting motor response to levodopa in PD given its significant associations with the clinical factors evaluated.
10
Staging of brain pathology related to sporadic Parkinson’s disease
Heiko Braak, Kelly Del Tredici, Udo Rüb et al. · Neurobiology of Aging · 2002 · 10.8K citations
Medicine, Neurology, Neuroscience +13
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up
María Rodríguez‐Oroz, José Á. Obeso, Anthony E. Lang et al. · Brain · 2005 · 1.1K citations · Full text
Gender differences in Parkinson's disease
Charlotte A. Haaxma, Bastiaan R. Bloem, George F. Borm et al. · Journal of Neurology Neurosurgery & Psychiatry · 2006 · 750 citations · Full text
Medicine, Neurology, Neuroscience +17